About international stem cell corp - ISCO
International Stem Cell Corp. operates as a research and development company for the therapeutic market. It focuses on advancing potential clinical applications of human parthenogenetic stem cells for the treatment of various diseases of the central nervous system and liver diseases. The firm operates through three segments: Therapeutic Market, Biomedical Market and Anti-Aging Market. The Biomedical Market segment markets and sells primary human cell research products with two product categories, cells and media. The Anti-Aging market segment markets and sells a line of skincare products sold through two sales channels: ecommerce and professional. The ecommerce channel sells direct to customers through online orders, while professional sales are to spas, salons and other skincare providers. The Therapeutic Market segment focuses on the research and development of human parthenogenetic stem cells for the treatment of diseases of the central nervous system, liver diseases and is currently conducting clinical trials for the treatment of Parkinson's disease. The company was founded by William B. Adams, Kenneth C. Aldrich and Gregory S. Keller in June 2005 and is headquartered in San Diego, CA.
ISCO At a Glance
International Stem Cell Corp.
9745 Businesspark Avenue
San Diego, California 92131
| Phone | 1-760-940-6383 | Revenue | 9.09M | |
| Industry | Medical Specialties | Net Income | -209,000.00 | |
| Sector | Health Technology | 2024 Sales Growth | 16.639% | |
| Fiscal Year-end | 12 / 2025 | Employees | 32 | |
| View SEC Filings |
ISCO Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 0.072 |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | 50.06 |
| Enterprise Value to EBITDA | 54.041 |
| Enterprise Value to Sales | 0.833 |
| Total Debt to Enterprise Value | 0.508 |
ISCO Efficiency
| Revenue/Employee | 283,906.25 |
| Income Per Employee | -6,531.25 |
| Receivables Turnover | 8.587 |
| Total Asset Turnover | 1.703 |
ISCO Liquidity
| Current Ratio | 0.759 |
| Quick Ratio | 0.514 |
| Cash Ratio | 0.262 |
ISCO Profitability
| Gross Margin | 57.666 |
| Operating Margin | -0.726 |
| Pretax Margin | -2.30 |
| Net Margin | -2.30 |
| Return on Assets | -3.917 |
| Return on Equity | -86.542 |
| Return on Total Capital | -4.964 |
| Return on Invested Capital | -40.077 |
ISCO Capital Structure
| Total Debt to Total Equity | 1,037.838 |
| Total Debt to Total Capital | 91.211 |
| Total Debt to Total Assets | 72.70 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | 2.732 |